The Movie Studio, Inc. (OTC PINK: MVES) Engages PCAOB

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
201
The Movie Studio, Inc. (OTC PINK: MVES) Engages PCAOB Auditing Firm to Proceed to Fully Reporting Status and Effectuate Agreement to Receive up to $5 Million Investment From GPL Ventures LLC

HALLANDALE BEACH, FL--(Marketwired - May 22, 2017) - The Movie Studio, Inc. ("MVES") (the "Company") ( OTC PINK : MVES ) www.themoviestudio.com .

The Movie Studio intends to proceed towards audited, fully reporting status as required with the filing of an S-1 Registration Statement with the SEC. As part of the process on May 17th, 2017, the Company entered into an engagement agreement with a PCAOB Member Accounting firm to audit the Company's 2015 and 2016 financial statements.

"We are taking the necessary steps to provide a higher level of transparency for our shareholders, investors and market makers as well as facilitate our executed agreement with GPL Ventures," stated Gordon Scott Venters, CEO of The Movie Studio Inc.

Pursuant to the executed Securities Purchase Agreement, the Company at its sole and exclusive option, may issue and sell to GPL shares of the Company's common stock equal to a value of up to Five Million Dollars ($5,000,000). The agreement requires that The Movie Studio file an S-1 Registration Statement and that it is deemed effective by the SEC qualifying the Company's Shares under Regulation A. Upon the S-1 Registration being deemed effective, the Company may now elect to trade on the OTCQB, OTCQX or other larger national markets subject to meeting minimum requirements.

In related news, on May 4th, 2017 OTC Markets announced that current Alternative Reporting Companies such as The Movie Studio are now eligible for the OTCQB Venture Market with the following requirements.

NEW OTCQB VENTURE MARKET MINIMUM REQUIREMENTS:

  • U.S. companies must have audited annual financials by a PCAOB auditor.
  • Minimum bid price of $0.01 per share for thirty consecutive days prior to listing
  • The Board of Directors must consist of two independent officers/directors
  • The Audit Committee must consist of two independent officers/directors

More information on the new OTCQB minimum requirements is available on the OTC Markets website. http://www.otcmarkets.com/services/companies/...quirements

According to OTC Markets the new standards give Alternative Reporting Companies an efficient way to raise their profile among investor and broker dealer communities, access greater liquidity and trade on an SEC recognized market, removing the trading restrictions placed on Pink Market securities.

Charles Miller, COO of The Movie Studio, stated, "The new OTCQB requirements could accelerate the Company toward its goal of moving up from the OTC Pink Market. This is welcome news for the Company and its shareholders."

About The Movie Studio Inc. The Movie Studio, Inc. is a vertically integrated motion picture production and distribution Company with completed motion picture and production assets. The Company acquires, develops, manufactures, and distributes independent motion picture content for worldwide consumption in Theatrical, Video on Demand (VOD), Foreign Sales and on various media devices. For more information, visit http://themoviestudio.com/ .

Forward Looking Statements and Disclaimer Statements made in this press release that express the Company or management's intentions, plans, beliefs, expectations or predictions of future events, are forward-looking statements. The words "believe," "expect," "intend," "estimate," "anticipate," "will" and similar expressions are intended to further identify such forward-looking statements, although not all forward-looking statements contain these identifying words. Those statements are based on many assumptions and are subject to many known and unknown risks, uncertainties and other factors that could cause the Company's actual activities, results or performance to differ materially from those anticipated or projected in such forward-looking statements. The Company cannot guarantee future financial results; levels of activity, performance or achievements and investors should not place undue reliance on the Company's forward-looking statements. No information contained in this press release should be construed as any indication whatsoever of the Company's future financial performance, future revenues or its future stock price. The forward-looking statements contained herein represent the judgment of the Company as of the date of this press release, and the Company expressly disclaims any intent, obligation or undertaking to update or revise such forward-looking statements to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. No information in this press release should be construed as any indication whatsoever of the Company's future revenues or results of operations.

Contact: The Movie Studio, Inc. Gordon Scott Venters President and CEO Gulfstream Park 800 Silk Run Suite #1330 Hallandale Beach, Florida 33009 gsv@themoviestudio.com 954-332-6600 Telephone: 954-332-6600 Fax: 954-440-7818

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 637

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 254

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
"blog__more"> More News Articles